title: Ocriplasmin: a medical or surgical therapy?
authors.affiliation: *New England Eye Center, Tufts Medical Center, Tufts University School of Medicine, Boston, Massachusetts †Retina Associates of Kentucky, Lexington, Kentucky.
authors.forename: Jay S
authors.initials: JS
authors.lastname: Duker
authors.forename: Andrew A
authors.initials: AA
authors.lastname: Moshfeghi
mesh_terms: D005341:Fibrinolysin / Q000008:administration & dosage*; D005343:Fibrinolytic Agents / Q000008:administration & dosage*; D006801:Humans; D058449:Intravitreal Injections; D010446:Peptide Fragments / Q000008:administration & dosage*; D012164:Retinal Diseases / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D000267:Tissue Adhesions / Q000188:drug therapy / Q000601:surgery; D014822:Vitreous Body / Q000473:pathology*
chemical_list: D005343:Fibrinolytic Agents; D010446:Peptide Fragments; C054561:microplasmin; D005341:Fibrinolysin